I would like to welcome everyone to Aeva Technologies fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) As a reminder, today's conference call is being recorded and ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

Growing participation in international trade agreements: Vietnam’s active involvement in global trade pacts such as the Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP) ...

Enables AI platform to model and predict patient outcomes on historical samples Global biospecimen ... clinical trial optimization and target validation Proprietary tool accounts for patient ...

In a changing world, Paris Fashion Week remains a vital platform for culture and business, celebrating the power of art in ...

HDBuzz reported live updates on Bluesky from the 2025 HD Therapeutics Conference. Read on for coverage of Day 3. #CHDI2025 ...

Concurrent analysis of whole-genome DNA methylation and single-cell RNA sequencing data from COVID-19 patients and controls ...

In 2025, Beamr plans to leverage the strong market validation it has gained in numerous ... today issued a Letter to Shareholders from Sharon Carmel, Chief Executive Officer.

We believe that during 2025, Beamr will capitalize on the significant validation it has created in 2024 and convert prospects in the sales funnel into significant revenue growth in the next quarters.

Fraudsters are sending fake letters to charities claiming to be from the Charity Commission and requesting personal ...

U.S. Sen. Thom Tillis has stated that vetting Cabinet nominees is one of the most important aspects of his job. Here are some of the nominees he voted to confirm ...

On March 12, the US Securities and Exchange Commission (SEC), via a No Action Letter, issued interpretive guidance clarifying what ...